189 related articles for article (PubMed ID: 12919851)
1. Interleukin-12 but not interleukin-18 is required for immunity to Trypanosoma cruzi in mice.
Graefe SE; Jacobs T; Gaworski I; Klauenberg U; Steeg C; Fleischer B
Microbes Infect; 2003 Aug; 5(10):833-9. PubMed ID: 12919851
[TBL] [Abstract][Full Text] [Related]
2. Early IFN-gamma production is related to the presence of interleukin (IL)-18 and the absence of IL-13 in experimental Trypanosoma cruzi infections.
Antúnez MI; Cardoni RL
Immunol Lett; 2001 Dec; 79(3):189-96. PubMed ID: 11600197
[TBL] [Abstract][Full Text] [Related]
3. [TH1 response in the experimental infection with Trypanosoma cruzi].
Cardoni RL; Antúnez MI; Abrami AA
Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
[TBL] [Abstract][Full Text] [Related]
4. Trypanosoma cruzi: IL-10, TNF, IFN-gamma, and IL-12 regulate innate and acquired immunity to infection.
Abrahamsohn IA; Coffman RL
Exp Parasitol; 1996 Nov; 84(2):231-44. PubMed ID: 8932773
[TBL] [Abstract][Full Text] [Related]
5. Resistant mice lacking interleukin-12 become susceptible to Trypanosoma cruzi infection but fail to mount a T helper type 2 response.
Galvão Da Silva AP; Jacysyn JF; De Almeida Abrahamsohn I
Immunology; 2003 Feb; 108(2):230-7. PubMed ID: 12562332
[TBL] [Abstract][Full Text] [Related]
6. Macrophage migration inhibitory factor contributes to host defense against acute Trypanosoma cruzi infection.
Reyes JL; Terrazas LI; Espinoza B; Cruz-Robles D; Soto V; Rivera-Montoya I; Gómez-García L; Snider H; Satoskar AR; Rodríguez-Sosa M
Infect Immun; 2006 Jun; 74(6):3170-9. PubMed ID: 16714544
[TBL] [Abstract][Full Text] [Related]
7. CD28 is required for T cell activation and IFN-gamma production by CD4+ and CD8+ T cells in response to Trypanosoma cruzi infection.
Martins GA; Campanelli AP; Silva RB; Tadokoro CE; Russo M; Cunha FQ; Rizzo LV; Silva JS
Microbes Infect; 2004 Nov; 6(13):1133-44. PubMed ID: 15488732
[TBL] [Abstract][Full Text] [Related]
8. Regulatory effects of IL-18 on cytokine profiles and development of myocarditis during Trypanosoma cruzi infection.
Esper L; Utsch L; Soriani FM; Brant F; Esteves Arantes RM; Campos CF; Pinho V; Souza DG; Teixeira MM; Tanowitz HB; Vieira LQ; Machado FS
Microbes Infect; 2014 Jun; 16(6):481-90. PubMed ID: 24704475
[TBL] [Abstract][Full Text] [Related]
9. IL-12-independent IFN-gamma production by T cells in experimental Chagas' disease is mediated by IL-18.
Müller U; Köhler G; Mossmann H; Schaub GA; Alber G; Di Santo JP; Brombacher F; Hölscher C
J Immunol; 2001 Sep; 167(6):3346-53. PubMed ID: 11544324
[TBL] [Abstract][Full Text] [Related]
10. Leishmania sp: comparative study with Toxoplasma gondii and Trypanosoma cruzi in their ability to initialize IL-12 and IFN-gamma synthesis.
Oliveira MA; Santiago HC; Lisboa CR; Ceravollo IP; Trinchieri G; Gazzinelli RT; Vieira LQ
Exp Parasitol; 2000 Jun; 95(2):96-105. PubMed ID: 10910710
[TBL] [Abstract][Full Text] [Related]
11. Osteopontin-dependent regulation of Th1 and Th17 cytokine responses in Trypanosoma cruzi-infected C57BL/6 mice.
Santamaría MH; Corral RS
Cytokine; 2013 Feb; 61(2):491-8. PubMed ID: 23199812
[TBL] [Abstract][Full Text] [Related]
12. Pivotal role of interleukin-12 and interferon-gamma axis in controlling tissue parasitism and inflammation in the heart and central nervous system during Trypanosoma cruzi infection.
Michailowsky V; Silva NM; Rocha CD; Vieira LQ; Lannes-Vieira J; Gazzinelli RT
Am J Pathol; 2001 Nov; 159(5):1723-33. PubMed ID: 11696433
[TBL] [Abstract][Full Text] [Related]
13. During Trypanosoma cruzi infection CD1d-restricted NK T cells limit parasitemia and augment the antibody response to a glycophosphoinositol-modified surface protein.
Duthie MS; Wleklinski-Lee M; Smith S; Nakayama T; Taniguchi M; Kahn SJ
Infect Immun; 2002 Jan; 70(1):36-48. PubMed ID: 11748161
[TBL] [Abstract][Full Text] [Related]
14. STING Signaling Drives Production of Innate Cytokines, Generation of CD8
Vieira RS; Nascimento MS; Noronha IH; Vasconcelos JRC; Benvenuti LA; Barber GN; Câmara NOS; Kalil J; Cunha-Neto E; Almeida RR
Front Immunol; 2021; 12():775346. PubMed ID: 35095849
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 is required for parasite specific response and host resistance to Trypanosoma cruzi.
Gao W; Pereira MA
Int J Parasitol; 2002 Feb; 32(2):167-70. PubMed ID: 11812493
[TBL] [Abstract][Full Text] [Related]
16. Impact of Trypanosoma cruzi infection on nitric oxide synthase and arginase expression and activity in young and elderly mice.
Felizardo AA; Caldas IS; Mendonça AAS; Gonçalves RV; Tana FL; Almeida LA; Novaes RD
Free Radic Biol Med; 2018 Dec; 129():227-236. PubMed ID: 30248443
[TBL] [Abstract][Full Text] [Related]
17. Kinetic analysis of antigen-specific immune responses in resistant and susceptible mice during infection with Trypanosoma cruzi.
Hoft DF; Lynch RG; Kirchhoff LV
J Immunol; 1993 Dec; 151(12):7038-47. PubMed ID: 8258708
[TBL] [Abstract][Full Text] [Related]
18. Effects of interleukin-4 deprivation and treatment on resistance to Trypanosoma cruzi.
Abrahamsohn IA; da Silva AP; Coffman RL
Infect Immun; 2000 Apr; 68(4):1975-9. PubMed ID: 10722591
[TBL] [Abstract][Full Text] [Related]
19. IFN-gamma, IL-4, IL-10 and IL-12 gene expression in BCG-Leishmania vaccination of Trypanosoma cruzi-infected mice.
Araujo Z; Heremans H; Stordeur P; Wissing M; Goldman M; Castes M; Carlier Y
Vaccine; 2000 Mar; 18(17):1822-9. PubMed ID: 10699330
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-12 stimulation of lymphoproliferative responses in Trypanosoma cruzi infection.
Galvão da Silva AP; de Almeida Abrahamsohn I
Immunology; 2001 Nov; 104(3):349-54. PubMed ID: 11722650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]